The Joint Corp (JYNT)
Health Care · Health care services (franchisor) · NASDAQ
The Joint Corp. is the nation's largest franchisor of a retail-based, cash-pay model for routine, accessible chiropractic care.
What The Joint Corp does
The Joint Corp. is a franchisor of chiropractic clinics that operates using a private pay, non-insurance, cash-based model. The company supports a network of retail-based clinics that offer routine, appointment-free chiropractic adjustments. It is currently transitioning to a pure-play franchisor model by divesting its company-owned and managed clinic portfolio to focus on franchise system support and development.
Recent developments
The company has substantially completed its 'Joint 2.0' refranchising strategy, effectively transitioning to a capital-light, pure-play franchisor model. In Q2 2026, the company reported revenue growth of 14% to $15.2 million and strengthened cash flow from operations to $2.2 million, while continuing to execute share repurchases and regional developer territory buybacks.
From The Joint Corp's filing of 2026-08-07.
Themes: franchising / franchise business models, wellness / non-invasive health care, cash-pay healthcare models, consumer services
Fundamentals
- Price$7.19 as of 2026-10-20 close
- Market cap$102M as of 2026-08-03 (share count; price 2026-10-20)
- 1-year return-15.7% 2025-10-20 close $8.53 → 2026-10-20 close $7.19
- P/E27.65 as of 2026-10-20
- Net margin-8.3% FY2023, SEC XBRL
- ROE+19.3% FY2025, SEC XBRL
- ROICn/a No figure: its pre-tax income was zero or negative, so there is no tax rate to apply.
- Debt / equityn/a No figure: its filing tags none of the debt lines we read, which is not evidence of zero debt.
- Revenue CAGR (3y)+26.1% SEC XBRL
- Beta0.80 as of 2026-09-02
- Last reported earnings2026-08-06 SEC EDGAR Form 8-K (Item 2.02)
How JYNT compares in its sector
- price-to-earnings ratiomiddle range 181 covered Health Care peers, as of 2026-10-20
- net profit marginmiddle range 430 covered Health Care peers, as of 2026-09-02
- operating marginmiddle range 417 covered Health Care peers, as of 2026-09-02
- return on equitytop 25% 510 covered Health Care peers, as of 2026-09-02
- 3-year revenue CAGRtop 25% 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 494 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Quarterly results
| Quarter | Revenue | Operating income | Net income | Diluted EPS | Operating cash flow | Capex |
|---|---|---|---|---|---|---|
| Q2 FY2026 2026-06-30 | — | -$368657 | $653021 | $0.05 | $2M† | $256258† |
| Q1 FY2026 2026-03-31 | — | $873668 | $1M | $0.09 | -$1M | $234600 |
| Q4 FY2025 2025-12-31 | — | $742410 | $991097 | $0.07 | $3M† | $349400† |
| Q3 FY2025 2025-09-30 | — | $160915 | $855009 | $0.06 | $2M† | $317840† |
| Q2 FY2025 2025-06-30 | — | -$1M | $93363 | $0.01 | $868649† | $505040† |
| Q1 FY2025 2025-03-31 | — | -$678534 | $967796 | $0.06 | -$4M | $331505 |
| Q4 FY2024 2024-12-31 | — | $809716 | $17665 | $0.00 | $4M† | $284253† |
| Q3 FY2024 2024-09-30 | $30M | -$492820 | -$3M | -$0.21 | $3M† | $243944† |
† Not filed as a discrete quarter: derived from the company's own year-to-date figures (for example the fourth quarter as the fiscal year minus the first nine months). A derived per-share figure is approximate, because the share count moves within the year.
Balance sheet at 2026-06-30
- Cash and equivalents$22M
- Total debtnot shown the filing tags none of the debt lines we read — not evidence of zero debt
From the company's own SEC 10-Q and 10-K filings (XBRL), re-read every week. Figures in US dollars as filed; informational only — not financial advice.
How The Joint Corp looks technically
The Joint Corp (JYNT) is trading 17.1% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 52 trading days ago — a "death cross", a bearish long-term signal. A strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 29, with sellers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 39, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 2 trading days ago (its momentum flipped positive). It made a new 20-day low about 5 trading days ago. It is 32.6% below its highest point of the past year. Trading volume is unusually light — only about 43% of its 30-day average.
Trend
7
| Distance from the 200-day | it is trading 17.1% below its 200-day average, the long-term trend line — a long-term downtrend | -17.1% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $7.98 | $7.98 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $8.68 | $8.68 |
| Swing structure | its recent peaks and dips disagree — one of them is rising while the other is not, so there is no clean up or down pattern in the swings | mixed — one of the two is not confirming |
| Last swing turn | its last significant turn was a swing high 32 calendar days ago — the swings before that are what the structure reading is measured on | 32 sessions |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 52 trading days ago — a "death cross", a bearish long-term signal | 52 sessions |
| Trend strength (14-day ADX) | a strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 29, with sellers in control | 29.0 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 39, neither overbought (above 70) nor oversold (below 30) | 39.4 |
|---|---|---|
| Position in its 14-day range | it is trading around the middle of its 14-day range ($6.79 to $7.60) — its "stochastic" reading is 49 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 49.4 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 2 trading days ago (its momentum flipped positive) | 2 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $10.67 | $10.67 |
|---|---|---|
| From the 52-week high | it is 32.6% below its 52-week high (its highest price of the past year) | -32.6% |
| Above the 52-week low | it is 5.9% above its 52-week low (its lowest price of the past year) | +5.9% |
| Below the 52-week high | it is 32.6% below its highest point of the past year | 32.6% |
| Since a 20-day breakout | it made a new 20-day low about 5 trading days ago | 5 sessions |
| Since a 55-day breakout | it made a new 55-day low about 5 trading days ago | 5 sessions |
| All-time high | its highest closing price on record is $111.06 (set on 2021-09-07) | $111.06 |
| Given back of the 52-week move | over the past year its closes ranged ($6.90 to $10.53), and it has recovered only a small part of its fall from last year’s high — 8% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $9.14 to $9.26. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 8.0% |
| From the all-time high | it is 93.5% below its all-time high | -93.5% |
| Nearest price level | it is trading 8.8% below a resistance level at $7.82 — a price it turned at twice since 2026-03-20, most recently on 2026-09-11. Since 2024-10-21 it has 0 such levels below the current price and 15 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +8.8% |
| All-time low | its lowest closing price on record is $1.85 (set on 2016-07-01) | $1.85 |
| Above the all-time low | it is 288.6% above its all-time low | +288.6% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually wide versus its own recent history (wider than about 93% of the past ~6 months) | 93rd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.2614 between its high and its low — about 3.6% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.2614 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $6.44 and $8.33 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $6.44 – $7.39 – $8.33 |
| Typical daily range (% of price) | its price moves about 3.6% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 3.6% |
| Stretch from the 200-day average | it is trading 5.7 daily ranges below its 200-day average price (17.2% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 5.7 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is unusually light — only about 43% of its 30-day average | 0.43× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
1
| Since a doji | 3 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 3 sessions ago |
|---|
Price gaps
2
| Gap at the open | it opened on 2026-10-20 at essentially the same price it closed at the session before — no meaningful overnight gap | 0.0% |
|---|---|---|
| Gap filled | a 2.5% gap up opened on 2026-08-18 has been "filled" 43 sessions ago — price traded back through the level the gap left behind, and it took 1 session to close | 43 sessions ago |
Price streaks
1
| Closing streak | it closed lower in its latest session, after a session that did not close lower — a single down day rather than a run | 1 session down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 15.8 percentage points (the stock lost 14.8% while the market gained 1.0%) | -15.8% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 21.1 percentage points (the stock lost 17.5% while the market gained 3.6%) | -21.1% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 26.7 percentage points (the stock lost 18.2% while the market gained 8.5%) | -26.7% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 30.3 percentage points (the stock lost 15.7% while the market gained 14.6%) | -30.3% |
Signal agreement
2
| Bullish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bullish state: MACD momentum is positive — these describe past price behaviour, not a forecast | 1 of 9 |
|---|---|---|
| Bearish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, a strong downtrend, with sellers in control, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 5 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 13% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-14 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 5.6% of the share price. | -12.8% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 16% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $8.60 — a volume-weighted average of daily closes over 199 sessions, not a true tick-by-tick VWAP. | -16.4% |
|---|---|---|
| Vs the average paid since it last reported | the price is 10% below the average price paid since it last reported on 2026-08-06 (its 8-K), so the typical buyer over that stretch is under water. That average is $8.02 — a volume-weighted average of daily closes over 53 sessions, not a true tick-by-tick VWAP. | -10.3% |
Price levels it has turned at before
JYNT last closed at $7.19 on 2026-10-20. Since 2024-10-21 it has turned at 0 prices below its last close and 15 above; the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $7.82 | Resistance | 8.8% above the last close | turned there twice · 2026-03-20 to 2026-09-11 |
| $8.07 | Resistance | 12.3% above the last close | turned there 7 times · 2025-10-13 to 2026-08-19 |
| $8.32 | Resistance | 15.7% above the last close | turned there twice · 2026-02-12 to 2026-06-29 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-10-20.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Trading below the 50-day moving average · Pulled back from the 12-month high · MACD just crossed bullish (12/26/9) · lagging the market · Under water since its last earnings report (below the anchored VWAP) | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low · volume and relative volume
Based on daily closing prices as of 2026-10-20. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$10.00 range $9.00 – $12.00; median $9.00
Analyst estimates, as of 2026-10-17. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for JYNT
- Consensus EPS estimate$0.08 next reporting period, as of 2026-10-17
- Estimate change, 30 days$0.00 from $0.08, on 2026-09-12, 35-day window
- Readings revised upward0% of 9 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Nationwide labor shortages and the difficulty in recruiting/retaining qualified chiropractors, which impacts clinic operating capacity.","Potential for reduced discretionary consumer spending due to inflationary pressures.","Risks associated with the strategic refranchising of corporate-owned clinics and the potential failure to maintain consistent quality or growth across a decentralized franchisee network."]
What changed in the latest 10-Q
AI-assisted comparison of JYNT's 10-Q filed 2026-08-07 against the prior one filed 2026-05-08.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-08-07) adds second quarter 2026 performance metrics: Comp sales decreased 2.8% and system-wide sales decreased 3.7% to $128.0 million for the three months ended June 30, 2026.
- Newer filing (2026-08-07) adds clinic counts as of June 30, 2026: 941 total clinics, 896 franchisee-operated, 45 company-owned or managed.
- Newer filing (2026-08-07) adds that franchisees opened five clinics in the second quarter of 2026, compared to seven in the second quarter of 2025.
- Newer filing (2026-08-07) adds that during the quarter ended June 30, 2026, the company closed on the sale of one clinic included in the Addisco Value, LLC transaction.
- Newer filing (2026-08-07) adds that on April 27, 2026, the company closed on the sale of 13 clinics included in the Elite Chiro Group Transaction, at which time ownership transferred to Elite Chiro Group.
- Removed:
- Older filing (2026-05-08) includes clinic counts as of March 31, 2026: 943 total clinics, 868 franchisee-operated, 75 company-owned or managed.
- Older filing (2026-05-08) includes that franchisees opened three clinics in the first quarter of 2026, compared to five in the first quarter of 2025.
- Older filing (2026-05-08) includes a statement that on March 2, 2026, the company signed a LOI with a new potential buyer for five company-owned or managed clinics located in Northern California.
- Older filing (2026-05-08) includes a statement that on March 31, 2026, the company acquired regional developer territory rights in the state of Ohio from one of its regional developers, with an upfront regional developer fee liability balance of $37 thousand.
- Older filing (2026-05-08) includes references to individual guarantors (Alex Klaus, Todd Wegerski, DC, Lisa Ezell, Andrew Michael Evec, and Susan Ruth Train) in the Addisco Value, LLC Asset Purchase Agreement.
- Reworded:
- Older filing (2026-05-08) says "We will continue our rapid and franchised focused expansion"; newer filing (2026-08-07) removes the word "rapid".
- Notes:
- The newer filing text is truncated at the end of a sentence ("On April 27, 2026, Elite Chiro Group"), so the complete newer version of that paragraph could not be compared.
- The older filing text is truncated at "The closing of each clinic as part of the Elite Chiro Group Transaction is exp", so the older version of that paragraph is incomplete and cannot be fully compared.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days, of which we have read Form 4 filings through 2026-10-16. The 5 days since 2026-10-16 have not been checked yet.
- Last 180 days · read to 2026-10-162 buys ($1M) · 0 sells — 1 buying insider
Most recent open-market transaction: 2026-05-13. Based on Form 4 filings read through 2026-10-16; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about JYNT's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding JYNT as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 1,100,482
- Reported value $9,662,232
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 1 increased, 4 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about JYNT's institutional holders → See what each manager we track holds →
Short interest (FINRA)
JYNT had 405,587 shares of reported short interest as of the 2026-09-30 FINRA settlement date (delayed, bi-monthly; not real-time).
JYNT had 2.87% of its shares outstanding sold short as of the 2026-09-30 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 4.3 days to cover at the same settlement.
- Reported short interest (shares) 405,587
- Short interest (% of shares outstanding) 2.87%
- Prior settlement (shares) 439,478
- Reported change -7.71%
- Days to cover (reported) 4.3
Reported to FINRA as of the 2026-09-30 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- The specific market for regional/local chiropractic practices (fragmented)
- traditional chiropractic practitioners
- physical therapy and other non-invasive wellness clinics
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Frequently asked questions
What does The Joint Corp (JYNT) do?
The Joint Corp. is a franchisor of chiropractic clinics that operates using a private pay, non-insurance, cash-based model. The company supports a network of retail-based clinics that offer routine, appointment-free chiropractic adjustments. It is currently transitioning to a pure-play franchisor model by divesting its company-owned and managed clinic portfolio to focus on franchise system support and development.
What sector is The Joint Corp (JYNT) in?
The Joint Corp (JYNT) is classified in the Health Care sector. Its industry is Health care services (franchisor). It trades on NASDAQ.
Who are The Joint Corp's (JYNT) competitors?
Notable peers of The Joint Corp (JYNT) include The specific market for regional/local chiropractic practices (fragmented), traditional chiropractic practitioners and physical therapy and other non-invasive wellness clinics. This peer set is informational only — not financial advice.
Is The Joint Corp (JYNT) overbought or oversold right now?
The Joint Corp (JYNT) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 39, in the neutral middle (as of 2026-10-20). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on JYNT come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest; prices are market data, as of 2026-09-02; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.